Editorial introductions

Abstract

Current Opinion in Endocrinology and Diabetes was launched in 1994, with Obesity added to the title in 2007. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of endocrinology and diabetes are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce one of the Journal's Section Editors for this issue. SECTION EDITORS Anand VaidyaAnand VaidyaDr Anand Vaidya completed his medical education at Harvard Medical School, USA. He subsequently remained in Boston at Harvard Medical School for the remainder of his post-graduate training, where he completed an internship and residency in internal medicine, and a clinical and research fellowship in endocrinology and metabolism, both at the Brigham and Women's Hospital, USA. Dr Vaidya received a Masters degree in human clinical investigation from Harvard Medical School before joining the faculty of the Division of Endocrinology, Diabetes, and Hypertension at the Brigham and Women's Hospital, and since then has continued his career as a physician-scientist and educator there. Dr. Vaidya is the Director of the Center for Adrenal Disorders at Brigham and Women's Hospital. He oversees the multi-disciplinary clinical care of patients with all forms of adrenal hormonal and neoplastic disorders. Dr. Vaidya's research program employs patient-oriented and population-based methods to investigate the causes and consequences of adrenal neoplasia, and how subclinical adrenal hormone excess can influence cardiometabolic risk. Dr Vaidya completed his medical education at Harvard Medical School and completed his clinical training at Brigham and Women's Hospital. David HandelsmanDavid HandelsmanDavid Handelsman is Professor of Reproductive Endocrinology and Andrology, at the University of Sydney and inaugural Director of the ANZAC Research Institute and head of Andrology Department, Concord Hospital, Australia. His interests in andrology (male reproductive health, medicine and biology) involve basic, clinical, translation and public health research centred on the physiology, pharmacology and toxicology of androgens. Recent research has focused on genetic mouse models of tissue-specific androgen action, steroid mass spectrometry, anti-doping science and the clinical pharmacology, misuse and abuse of androgens.